334 related articles for article (PubMed ID: 34572272)
1. The Role of Curcumin in Cancer Treatment.
Zoi V; Galani V; Lianos GD; Voulgaris S; Kyritsis AP; Alexiou GA
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572272
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
3. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
4. Intranasal curcumin regulates chronic asthma in mice by modulating NF-ĸB activation and MAPK signaling.
Chauhan PS; Singh DK; Dash D; Singh R
Phytomedicine; 2018 Dec; 51():29-38. PubMed ID: 30466625
[TBL] [Abstract][Full Text] [Related]
5. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C
Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891
[TBL] [Abstract][Full Text] [Related]
6. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
7. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway.
Wang SL; Li Y; Wen Y; Chen YF; Na LX; Li ST; Sun CH
Biomed Environ Sci; 2009 Feb; 22(1):32-9. PubMed ID: 19462685
[TBL] [Abstract][Full Text] [Related]
8. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells.
Kim YS; Ahn Y; Hong MH; Joo SY; Kim KH; Sohn IS; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jul; 50(1):41-9. PubMed ID: 17666914
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
Lee JS; Kim J; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
[TBL] [Abstract][Full Text] [Related]
10. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer.
Mukherjee D; Krishnan A
World J Methodol; 2023 Jun; 13(3):29-45. PubMed ID: 37456978
[TBL] [Abstract][Full Text] [Related]
13. Curcumin in combined cancer therapy.
Troselj KG; Kujundzic RN
Curr Pharm Des; 2014; 20(42):6682-96. PubMed ID: 25341940
[TBL] [Abstract][Full Text] [Related]
14. Curcumin as a natural regulator of monocyte chemoattractant protein-1.
Karimian MS; Pirro M; Majeed M; Sahebkar A
Cytokine Growth Factor Rev; 2017 Feb; 33():55-63. PubMed ID: 27743775
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation.
Chun KS; Keum YS; Han SS; Song YS; Kim SH; Surh YJ
Carcinogenesis; 2003 Sep; 24(9):1515-24. PubMed ID: 12844482
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits UVB-induced matrix metalloproteinase-1/3 expression by suppressing the MAPK-p38/JNK pathways in human dermal fibroblasts.
Hwang BM; Noh EM; Kim JS; Kim JM; You YO; Hwang JK; Kwon KB; Lee YR
Exp Dermatol; 2013 May; 22(5):371-4. PubMed ID: 23614750
[TBL] [Abstract][Full Text] [Related]
17. The targets of curcumin.
Zhou H; Beevers CS; Huang S
Curr Drug Targets; 2011 Mar; 12(3):332-47. PubMed ID: 20955148
[TBL] [Abstract][Full Text] [Related]
18. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
Qadir MI; Naqvi ST; Muhammad SA
Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.
Surh YJ; Chun KS; Cha HH; Han SS; Keum YS; Park KK; Lee SS
Mutat Res; 2001 Sep; 480-481():243-68. PubMed ID: 11506818
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
